Sphere Fluidics – Parkwalk closes further funding round
We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously. Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D… Read More
Sphere Fluidics – University of Cambridge Enterprise Fund III closes further funding round
We have closed an investment, in a $7m funding round, in Sphere Fluidics for the University of Cambridge Enterprise Fund III. This follows the UCEFs I and II investing previously. The investment round has been led by an Asian corporate investor Sphere Fluidics… Read More
Sphere Fluidics – Parkwalk closes further funding round
We have closed an investment, in the first tranche of a financing round of up to £2m, in Sphere Fluidics for the University of Cambridge Enterprise Fund II and the final investment for Parkwalk Fund IV. This follows the UoCEF I… Read More
Cambridge Enterprise
A huge thank you to all the team at Cambridge Enterprise for an excellent University of Cambridge Enterprise Fund investor evening yesterday at Emmanuel College. Investee companies presenting included: Aqdot (highlighted in the FT yesterday) Cambridge CMOS Sensors DefiniGEN… Read More
Sphere Fluidics
Wins ACES award for academic spin-outs University of Cambridge spin-out Sphere Fluidics was among the winners at the ACES awards – the only pan-European awards for academic spin-outs – held earlier this week in Brussels.
Sphere Fluidics
Parkwalk closes Sphere Fluidics investment for the University of Cambridge Enterprise Fund I Sphere Fluidics has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D services. A novel technology platform (called Cyto-MineTM)… Read More
